Charles River to Supply Pfizer's Genetically Modified Research Models

March 3, 2011 - Charles River has entered into a marketing and distribution agreement with Pfizer, Inc., to provide certain Pfizer-developed genetically modified research models to the global biomedical research community. The Pfizer strains encompass several different therapeutic areas, including CNS, diabetes, inflammation and cardiovascular disease. The table below contains general details on each strain. Additional information can be accessed by clicking on each strain line’s name or the corresponding publication link (if available).

The ordering process is simple and straightforward, and our team of animal specialists can work with you to make all the necessary shipping arrangements and answer any questions you may have. As an industry leader in colony development and animal production services, we are pleased to feature these valuable Pfizer strains in our growing portfolio of research models and animal support services.

For more information or to receive a quote, please contact us at askcharlesriver@crl.com.

Note: These models may be subject to the licensed patents and are sold only for research purposes under agreement from Pfizer, Inc.